Vasostrict 20 UNT/ML Injectable Solution
- RxCUI
- 1593738
- RxNorm name
- Vasostrict 20 UNT/ML Injectable Solution
- Display name
- Vasostrict 20 UNT/ML Injectable Solution
- Full name
- Vasostrict 20 UNT/ML Injectable Solution
- Term type
- SY
- Status
- DailyMed mapping
- Updated
- 2026-06-04 23:39:16
UNII Substances#
No records found.
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| Vasostrict | VASOPRESSIN | Par Health USA, LLC | b1147beb-743e-4c62-8927-91192447f8b8 | 2026-04-21 | Warnings, Adverse reactions | 1593738 |
| Vasostrict | VASOPRESSIN | Medical Purchasin Solutions, LLC | 6672a5c9-bcfd-d7fc-e053-2991aa0aef88 | 2023-06-01 | Warnings, Adverse reactions | 1593738 |
DailyMed RxNorm Mappings#
| Set ID | RxNorm mappings | Terms | SPL version | Label | Effective |
|---|---|---|---|---|---|
| b1147beb-743e-4c62-8927-91192447f8b8 | Vasostrict 20 UNT/ML Injectable Solution [PSN] · vasopressin (USP) 20 UNT/ML Injectable Solution [Vasostrict] [SBD] · Vasostrict 20 UNT/ML Injectable Solution [SY] | 3 | 49 | These highlights do not include all the information needed to use VASOSTRICT ® safely and effectively. See full prescribing information for VASOSTRICT ® . VASOSTRICT ® (vasopressin injection) for intravenous use VASOSTRICT ® (vasopressin in dextrose injection) for intravenous use Initial U.S. Approval: 2014 | 20260421 |
| 6672a5c9-bcfd-d7fc-e053-2991aa0aef88 | Vasostrict 20 UNT/ML Injectable Solution [PSN] · vasopressin (USP) 20 UNT/ML Injectable Solution [Vasostrict] [SBD] · Vasostrict 20 UNT/ML Injectable Solution [SY] | 3 | 3 | These highlights do not include all the information needed to use VASOSTRICT ® safely and effectively. See full prescribing information for VASOSTRICT ® . Vasostrict ® (vasopressin injection) for intravenous use Initial U.S. Approval: 2014 | 20230601 |